https://jamanetwork.com/journals/jamadermatology The Most Cited articles published by JAMA Dermatology en-us Mon, 01 Jul 2024 05:43:33 GMT Mon, 01 Jul 2024 05:43:33 GMT Silverchair [email protected] [email protected] https://jamanetwork.com/journals/jamadermatology/fullarticle/2790344 Sun, 01 May 2022 00:00:00 GMT This epidemiological assessment uses the GLOBOCAN database to evaluate the numbers of new cases and deaths due to cutaneous melanoma globally and by world region in 2020 and to estimate global values in 2040. 158 5 495 503 10.1001/jamadermatol.2022.0160 2790344 https://jamanetwork.com/journals/jamadermatology/fullarticle/2782803 Wed, 01 Sep 2021 00:00:00 GMT This randomized clinical trial assesses the safety and efficacy of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis. 157 9 1047 1055 10.1001/jamadermatol.2021.3023 2782803 https://jamanetwork.com/journals/jamadermatology/fullarticle/2781378 Sun, 01 Aug 2021 00:00:00 GMT This cross-sectional study uses data from the National Health and Nutrition Examination Survey to assess the prevalence of psoriasis in adults in the US and how it has changed since 2003. 157 8 940 946 10.1001/jamadermatol.2021.2007 2781378 https://jamanetwork.com/journals/jamadermatology/fullarticle/2789438 Fri, 01 Apr 2022 00:00:00 GMT This analysis of 2 randomized clinical trials evaluates long-term (52 weeks) efficacy and safety of upadacitinib treatment in patients with atopic dermatitis. 158 4 404 413 10.1001/jamadermatol.2022.0029 2789438 https://jamanetwork.com/journals/jamadermatology/fullarticle/2780049 Sun, 01 Aug 2021 00:00:00 GMT This systematic review and meta-analysis estimates worldwide hidradenitis suppurativa prevalence. 157 8 924 931 10.1001/jamadermatol.2021.1677 2780049 https://jamanetwork.com/journals/jamadermatology/fullarticle/2784295 Mon, 01 Nov 2021 00:00:00 GMT This scoping review analyzes the literature on algorithms assessing skin disease for data set criteria, emphasizing transparency and concerns about bias. 157 11 1362 1369 10.1001/jamadermatol.2021.3129 2784295 https://jamanetwork.com/journals/jamadermatology/fullarticle/2782805 Mon, 01 Nov 2021 00:00:00 GMT This randomized clinical trial assesses whether bimekizumab is efficacious and safe when used to treat patients with hidradenitis suppurativa. 157 11 1279 1288 10.1001/jamadermatol.2021.2905 2782805 https://jamanetwork.com/journals/jamadermatology/fullarticle/2782806 Fri, 01 Oct 2021 00:00:00 GMT This randomized clinical trial examines the efficacy and safety of abrocitinib plus topical therapy in adolescents with moderate-to-severe atopic dermatitis. 157 10 1165 1173 10.1001/jamadermatol.2021.2830 2782806 https://jamanetwork.com/journals/jamadermatology/fullarticle/2790388 Sun, 01 May 2022 00:00:00 GMT This living systematic review and network meta-analysis examines the association of systemic treatments for atopic dermatitis with scores on the Eczema Area and Severity Index, Patient Oriented Eczema Measure, Dermatology Life Quality Index, and Peak Pruritus Numeric Rating Scales. 158 5 523 532 10.1001/jamadermatol.2022.0455 2790388 https://jamanetwork.com/journals/jamadermatology/fullarticle/2784048 Mon, 01 Nov 2021 00:00:00 GMT This case series study of 8 French men examines clinical and pathological skin manifestations and their pathophysiology in VEXAS syndrome. 157 11 1349 1354 10.1001/jamadermatol.2021.3344 2784048 https://jamanetwork.com/journals/jamadermatology/fullarticle/2786912 Sat, 01 Jan 2022 00:00:00 GMT This consensus statement consolidates the limited existing literature with expert opinion to create a checklist to guide developers and reviewers of dermatology artificial intelligence. 158 1 90 96 10.1001/jamadermatol.2021.4915 2786912 https://jamanetwork.com/journals/jamadermatology/fullarticle/2787886 Tue, 01 Feb 2022 00:00:00 GMT This cohort study examines the association of developing cutaneous immune-related adverse events following treatment with anti–PD-1 or anti–PD-L1 therapy with patient survival. 158 2 189 193 10.1001/jamadermatol.2021.5476 2787886 https://jamanetwork.com/journals/jamadermatology/fullarticle/2781364 Sun, 01 Aug 2021 00:00:00 GMT This cohort study examines cutaneous reactions in hospital employees who received messenger RNA COVID-19 vaccination. 157 8 1000 1002 10.1001/jamadermatol.2021.2114 2781364 https://jamanetwork.com/journals/jamadermatology/fullarticle/2794033 Sat, 01 Oct 2022 00:00:00 GMT This cohort study examines the drug survival associated with the effectiveness and safety of commonly used biologics for psoriasis in the UK and Ireland. 158 10 1131 1141 10.1001/jamadermatol.2022.2909 2794033 https://jamanetwork.com/journals/jamadermatology/fullarticle/2792451 Fri, 01 Jul 2022 00:00:00 GMT This cross-sectional study uses data from the National Health and Nutrition Examination Survey to examine the association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults. 158 7 745 753 10.1001/jamadermatol.2022.1609 2792451 https://jamanetwork.com/journals/jamadermatology/fullarticle/2784291 Mon, 01 Nov 2021 00:00:00 GMT This randomized clinical trial assesses the efficacy and safety of sirolimus among children with slow-flow vascular malformations to better delineate the indications for treatment. 157 11 1289 1298 10.1001/jamadermatol.2021.3459 2784291 https://jamanetwork.com/journals/jamadermatology/fullarticle/2795925 Tue, 01 Nov 2022 00:00:00 GMT This mendelian randomization study investigates the associations between inflammatory bowel disease, particularly Crohn disease and ulcerative colitis, and psoriasis and psoriatic arthritis. 158 11 1262 1268 10.1001/jamadermatol.2022.3682 2795925 https://jamanetwork.com/journals/jamadermatology/fullarticle/2788988 Fri, 01 Apr 2022 00:00:00 GMT This cohort study estimates the risk of stage-specific Merkel cell carcinoma recurrence and mortality over time since diagnosis. 158 4 382 389 10.1001/jamadermatol.2021.6096 2788988 https://jamanetwork.com/journals/jamadermatology/fullarticle/2782062 Wed, 01 Sep 2021 00:00:00 GMT This cohort study uses data from the French National Health Data System to assess the risk of serious infection among biologics and apremilast used to treat psoriasis, with etanercept as the comparator. 157 9 1056 1065 10.1001/jamadermatol.2021.2599 2782062 https://jamanetwork.com/journals/jamadermatology/fullarticle/2787622 Tue, 01 Feb 2022 00:00:00 GMT This case series examines the development of acute generalized exanthematous pustulosis. 158 2 176 183 10.1001/jamadermatol.2021.5390 2787622 https://jamanetwork.com/journals/jamadermatology/fullarticle/2788833 Fri, 01 Apr 2022 00:00:00 GMT This study examines whether there is an association between short-term exposure to air pollution and psoriasis flares. 158 4 375 381 10.1001/jamadermatol.2021.6019 2788833 https://jamanetwork.com/journals/jamadermatology/fullarticle/2788258 Tue, 01 Mar 2022 00:00:00 GMT This network meta-analysis examines whether minoxidil, dutasteride, or finasteride monotherapy is the most efficacious for the treatment of male androgenetic alopecia. 158 3 266 274 10.1001/jamadermatol.2021.5743 2788258 https://jamanetwork.com/journals/jamadermatology/fullarticle/2781706 Sun, 01 Aug 2021 00:00:00 GMT This systematic review and meta-analysis examines the emotional and psychological sequelae of hair loss in both men and women as measured by various quality-of-life and psychological tests. 157 8 963 970 10.1001/jamadermatol.2021.2196 2781706 https://jamanetwork.com/journals/jamadermatology/fullarticle/2800236 Wed, 01 Feb 2023 00:00:00 GMT This randomized clinical trial examines the efficacy and safety of lebrikizumab in combination with background topical corticosteroid therapy in adolescents and adults with moderate-to-severe atopic dermatitis. 159 2 182 191 10.1001/jamadermatol.2022.5534 2800236 https://jamanetwork.com/journals/jamadermatology/fullarticle/2781297 Sun, 01 Aug 2021 00:00:00 GMT This randomized clinical trial evaluates if the antimicrobial-producing coagulase-negative staphylococcus of a patient with atopic dermatitis can be autologously reintroduced to the same patient to inhibit survival of Staphylococcus aureus and improve clinical outcomes. 157 8 978 982 10.1001/jamadermatol.2021.1311 2781297 https://jamanetwork.com/journals/jamadermatology/fullarticle/2787957 Tue, 01 Mar 2022 00:00:00 GMT This systematic review identifies known hidradenitis suppurativa biomarkers, categorized by biomarker type, and critically evaluates their validity according to established criteria. 158 3 300 313 10.1001/jamadermatol.2021.4926 2787957 https://jamanetwork.com/journals/jamadermatology/fullarticle/2785895 Sat, 01 Jan 2022 00:00:00 GMT This survey study aims to estimate the point prevalence of vitiligo among US adults aged 18 to 85 years. 158 1 43 50 10.1001/jamadermatol.2021.4724 2785895 https://jamanetwork.com/journals/jamadermatology/fullarticle/2795308 Tue, 01 Nov 2022 00:00:00 GMT This systematic review and meta-analysis examines the risk of incident venous thromboembolism among patients with atopic dermatitis who were receiving treatment with Janus kinase inhibitors. 158 11 1254 1261 10.1001/jamadermatol.2022.3516 2795308 https://jamanetwork.com/journals/jamadermatology/fullarticle/2792714 Fri, 01 Jul 2022 00:00:00 GMT This randomized clinical trial tests the hypothesis that reflectance confocal microscopy reduces unnecessary lesion excision by more than 30% and identifies all melanoma lesions larger than 0.5 mm at baseline. 158 7 754 761 10.1001/jamadermatol.2022.1570 2792714 https://jamanetwork.com/journals/jamadermatology/fullarticle/2785614 Wed, 01 Dec 2021 00:00:00 GMT This cohort study investigates the association between melanomas diagnosed during routine skin checks and melanoma-specific and all-cause mortality. 157 12 1425 1436 10.1001/jamadermatol.2021.3884 2785614